Vascular effects of disrupting endothelial mTORC1 signaling in obesity

John J Reho1, Deng-Fu Guo1,2, Andreas M Beyer3

  • 1Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa.

Insights

Vascular mechanistic target of rapamycin complex 1 (mTORC1) signaling increases with obesity. However, this pathway activation is not essential for diet-induced endothelial dysfunction in mice.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Disease Research
  • Endothelial Function

Background:

  • The mechanistic target of rapamycin complex 1 (mTORC1) pathway is crucial for cardiovascular health.
  • Dysregulation of mTORC1 signaling is linked to cardiovascular diseases.
  • Obesity-associated endothelial dysfunction highlights the need to understand vascular signaling pathways.

Purpose of the Study:

  • To investigate the role of vascular mTORC1 signaling in obesity-induced endothelial dysfunction.
  • To determine if elevated mTORC1 signaling in obesity is a cause or consequence of endothelial impairment.
  • To assess the necessity of endothelial mTORC1 signaling for maintaining vascular function during obesity.

Main Methods:

  • Utilized mouse models fed high-fat/high-sucrose diets to induce obesity.
  • Examined aortic endothelial function and vascular mTORC1 signaling in obese mice.
  • Analyzed endothelial cells and visceral adipose vessels from obese human subjects.
  • Employing genetic manipulation to delete the Raptor subunit of mTORC1 in endothelial cells.

Main Results:

  • Chronic high-fat diet feeding in mice led to endothelial dysfunction and increased vascular mTORC1 signaling.
  • Obese human endothelial cells and adipose vessels showed a trend toward elevated mTORC1 signaling.
  • Genetic deletion of endothelial mTORC1 (Raptor) did not prevent or rescue diet-induced endothelial dysfunction.
  • Endothelial mTORC1 deficiency did not reverse endothelial dysfunction caused by high-fat/high-sucrose diet.

Conclusions:

  • Vascular mTORC1 signaling is upregulated in obesity.
  • Despite increased signaling, vascular mTORC1 activation is not required for the development of obesity-related endothelial dysfunction.
  • Targeting vascular mTORC1 may not be a viable strategy for treating obesity-induced endothelial impairment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K